A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
- 1 March 2009
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 373 (9667), 897-910
- https://doi.org/10.1016/s0140-6736(09)60325-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialThe Lancet, 2008
- Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trialThe Lancet, 2007
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Incomplete Neointimal Coverage of Sirolimus-Eluting Stents: Angioscopic FindingsJournal of the American College of Cardiology, 2006
- Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantationEuropean Heart Journal, 2005
- Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasoundJournal of the American College of Cardiology, 2002
- Initial and 6-Month Results of Biodegradable Poly- l -Lactic Acid Coronary Stents in HumansCirculation, 2000
- Quantitative coronary angiography (QCA) in interventional cardiology: Clinical application of QCA measurementsProgress in Cardiovascular Diseases, 1994
- Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease.Circulation, 1991